Allied Market Research

2025

Ngs-based Monitoring And Diagnostic Test Market

NGS-Based Monitoring and Diagnostic Test Market Size, Share, Competitive Landscape and Trend Analysis Report, by Products and Services, by Type, by Application and, by End-User : Opportunity Analysis and Industry Forecast, 2023-2032

IC : Other

Select an option
Author's: | Onkar Sumant
Publish Date:

Get Sample to Email

The report on Ngs-based monitoring and diagnostic test market provides related insights, information, and recommendation to market stakeholder to achieve their priorities and enable the growth by taking the right decisions. The research covers Ngs-based monitoring and diagnostic test market across multiple countries and companies. The report is based on rigorous research methodology, which includes extensive desk research using quantitative/statistical methods, qualitative analysis, and primary interviews. This report examines the market scope, revenue size, and growth of the global Ngs-based monitoring and diagnostic test market in value terms, and also tracks the key trends at regional level. Moreover, it includes qualitative analysis on different parameters such as impact on market size, regulatory framework, economic impact, key player strategies, and opportunity window. The company profile section of the report covers company overview, key executives, company snapshot, operating business segments, product/service portfolio, R&D expenditure, business performance, and key strategic moves & developments. The global Ngs-based monitoring and diagnostic test market is segmented depending on by products and services, by type, by application, by end-user.

Key Companies identified in the report are Roche Diagnostics, ThermoFisher Scientific, Agilent Technologies, Qiagen, Illumina, BGI Genomics, Bio-Rad Laboratories, Danaher Corporation, Perkin Elmer, F. Hoffmann - LaTooch AG

Deliverables:

  • Market size value forecast by country

  • Regional level market trends and dynamics

  • Porter’s Five Forces Model and PESTLE Analysis

  • Company profile, competition landscape inclusive of competition dashboard, heatmap analysis, and product/service offerings

  • Key developmental strategies and M&A activities

  • Country Wise market size and forecast for each segment

  • Market Share of Leading Players worldwide

Market Taxonomy

This Ngs-based monitoring and diagnostic test market is segmented on the basis of by products and services, by type, by application, by end-user. On the basis of region, the global Ngs-based monitoring and diagnostic test market is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

NGS-Based Monitoring and Diagnostic Test Market Report Highlights

Aspects Details
icon_5
By Products and Services
  • Products
  • Services
icon_6
By Type
  • Sequencing-based Tests
  • Imaging-based Tests
icon_7
By Application
  • Oncology
  • Reproductive Health
icon_8
By End-User
  • Clinical Diagnostics
  • Research Labs
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_10
Key Market Players

Agilent Technologies, Perkin Elmer, Danaher Corporation, Illumina, Qiagen, Bio-Rad Laboratories, ThermoFisher Scientific, Roche Diagnostics, F. Hoffmann - LaTooch AG, BGI Genomics

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

NGS-Based Monitoring and Diagnostic Test Market

Opportunity Analysis and Industry Forecast, 2023-2032